NEWS & ANNOUNCEMENTS
- Immune System Overactivated in HD
- The FDA approves a Phase IIB trial for ACR16
- In a Phase II trial, Dimebon was found to be safe and well-tolerated with indications of effectiveness for HD patients
- Learn about HDSA’s Social Security Disability Insurance and Medicare Initiative
HDSA EVENTS
- Annual Convention
- 2008 Summer Ca$h Bonanza
HDTrials.org, new clinical trial notification site is launched - Stanford HOPE site creates HD glossary for new HDSA website
HD Legislation Introduced to Congress
THE FACE OF HD
